Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Placenta. 2008 Nov 17;30(1):25–34. doi: 10.1016/j.placenta.2008.10.006

Fig. 1.

Fig. 1

Variants of soluble Flt in plasma from normal pregnant (NP) and preeclamptic women (PE). Western analysis for sFlt-1 was performed using antibody from Sigma, Inc. (St. Louis, MO) after heparin-agarose enrichment. Equal volume of plasma (100 μl) from each patient was used to enrich sFlt using heparin-agarose. (A) Representative Western blot profile demonstrating the 100 and 145 kDa major bands and (B) densitometric quantitation of these two sFlt-1 variants (n = 14 in each group; *p < 0.05).